Aerobic Exercise and Insulin Resistance: UK Guide

Aerobic exercise and insulin resistance are closely linked, with physical activity recognised as one of the most effective tools for improving how the body responds to insulin. Regular aerobic activity helps muscles absorb glucose more efficiently, reduces visceral fat, and lowers chronic inflammation, all of which contribute to better blood sugar control. Whether you have been diagnosed with type 2 diabetes, prediabetes, or are simply looking to reduce your metabolic risk, understanding how exercise works at a physiological level, and how much you need, can help you make informed decisions about your health.

How does aerobic exercise help with insulin resistance?

Aerobic exercise activates GLUT4 transporters in muscle cells, enabling glucose uptake without insulin signalling. Regular activity also reduces visceral fat and chronic inflammation, improving long-term insulin sensitivity.

Aerobic exercise improves insulin resistance by increasing the uptake of glucose into muscle cells through mechanisms that work independently of insulin itself. During sustained physical activity, contracting muscles activate a protein called GLUT4, which acts as a glucose transporter. This process allows cells to absorb blood glucose without relying on insulin signalling, effectively bypassing the impaired pathway that characterises insulin resistance.

Beyond the immediate effect during exercise, regular aerobic activity produces lasting adaptations. It increases the density of GLUT4 transporters in muscle tissue, improves mitochondrial function, and reduces chronic low-grade inflammation, all of which contribute to better insulin sensitivity over time. These changes mean the body requires less insulin to manage the same amount of blood glucose.

Aerobic exercise also helps reduce visceral adipose tissue, the fat stored around the abdominal organs that is strongly associated with insulin resistance. As visceral fat decreases, the release of inflammatory cytokines and free fatty acids that interfere with insulin signalling also falls. This creates a positive cycle in which exercise improves body composition, which in turn further enhances insulin sensitivity.

Research, including studies published in journals such as Diabetes Care, indicates that a single session of aerobic exercise can improve insulin sensitivity for up to 24 to 72 hours afterwards.^[6][7] This transient benefit underlines the importance of exercising consistently rather than sporadically, as the cumulative effect of regular sessions produces the most meaningful and sustained improvements in blood glucose regulation.

Which types of aerobic exercise are most effective for blood sugar control?

Moderate-intensity activities such as brisk walking, cycling, and swimming are well-evidenced for blood sugar control. HIIT can produce comparable benefits in less time but may not suit deconditioned individuals.

Moderate-intensity continuous exercise, such as brisk walking, cycling, swimming, and jogging, is among the most well-evidenced forms of aerobic activity for improving blood sugar control in people with or at risk of insulin resistance. The UK Chief Medical Officers describe moderate intensity as activity at which you can talk but not sing. This broadly corresponds to roughly 50 to 70 per cent of maximum heart rate capacity, and sustaining that effort over time is the range most consistently associated with improved glucose metabolism in clinical studies.

High-intensity interval training (HIIT), which alternates short bursts of vigorous effort with recovery periods, has also shown strong results in improving insulin sensitivity. Some research, including systematic reviews comparing HIIT with moderate-intensity continuous training in people with type 2 diabetes and prediabetes, suggests HIIT may produce comparable or superior improvements in glycaemic control in a shorter total time commitment. However, HIIT places greater demands on the cardiovascular system and joints, so it may not be appropriate for everyone, particularly those who are deconditioned or have comorbidities.

Walking deserves particular mention because it is accessible, low-cost, and carries a low injury risk. Studies have shown that breaking up prolonged sitting with short walking bouts of around 10 minutes, or even shorter activity breaks of 2 to 3 minutes, can meaningfully reduce postprandial (after-meal) blood glucose levels. This makes walking a practical starting point for people who are new to exercise or managing other health conditions alongside insulin resistance.

Water-based exercise, such as aqua aerobics or swimming, is especially useful for individuals with joint problems or obesity, as the buoyancy of water reduces mechanical load. Regardless of the specific activity chosen, consistency and enjoyment are key factors in long-term adherence, which ultimately determines how much benefit a person gains.

How much exercise do you need to see a real difference in insulin sensitivity?

At least 150 minutes of moderate-intensity aerobic exercise per week, spread across four to five days, produces meaningful improvements in insulin sensitivity. Increasing to 300 minutes per week offers additional metabolic benefits.

Meaningful improvements in insulin sensitivity can begin to appear with as little as 150 minutes of moderate-intensity aerobic exercise per week, spread across most days.^[8][9] This figure aligns with the UK Chief Medical Officers' physical activity guidelines for adults and is supported by a substantial body of clinical evidence in people with type 2 diabetes and prediabetes.

The distribution of exercise across the week matters as well as the total volume. Because the insulin-sensitising effect of a single session lasts approximately 24 to 72 hours, exercising on at least four to five days per week helps maintain a more consistent improvement in glucose regulation. Concentrating all activity into one or two days is less effective than spreading it more evenly, even if the total minutes are the same.

For those who are able to tolerate it, increasing to 300 minutes per week of moderate-intensity activity, or 150 minutes of vigorous activity, is associated with additional metabolic benefits, including greater reductions in HbA1c and fasting glucose, as set out in the UK CMO guidelines. The UK CMO guidelines also recommend muscle-strengthening activities, such as resistance exercises or heavy gardening, on at least two days per week, as these provide additional benefits for insulin sensitivity and overall metabolic health. Reducing prolonged sitting is also encouraged, as breaking up sedentary time has independent benefits for blood glucose.

Even modest increases from a sedentary baseline produce measurable improvements, so starting small and building gradually is a clinically sound approach. Progress should be gradual, particularly for people who have been inactive; a conservative approach is to increase duration or intensity in small steps over several weeks rather than making large jumps, and to listen to how the body responds. Tracking activity with a simple diary or wearable device can help individuals and their healthcare team monitor progress and adjust targets over time. If you are unsure where to start, your GP or a practice nurse can provide personalised guidance.

What does the NHS and NICE guidance say about exercise for insulin resistance?

NICE guideline NG28 recommends aerobic exercise as a first-line intervention for type 2 diabetes and prediabetes. The NHS Diabetes Prevention Programme provides structured physical activity support for eligible adults.

NICE recommends structured physical activity as a core component of lifestyle management for people with type 2 diabetes and those identified as being at high risk. NICE guideline NG28 (Type 2 diabetes in adults: management) and the associated prevention guidance both highlight aerobic exercise alongside dietary change as first-line interventions for improving glycaemic control and reducing cardiovascular risk.^[16][17]

In England, the NHS Diabetes Prevention Programme (also known as Healthier You) offers a structured behavioural intervention that includes physical activity support for adults with non-diabetic hyperglycaemia (prediabetes). Referral is typically made through a GP or following an NHS Health Check. The programme provides group-based education and coaching over several months, with exercise guidance tailored to individual ability and health status. Equivalent prevention programmes exist in Scotland, Wales, and Northern Ireland under different names and referral pathways; your GP can advise on what is available locally.

For people already diagnosed with type 2 diabetes, NICE recommends that healthcare professionals offer structured education and support to increase physical activity as part of an individualised care plan. This includes discussing the type, frequency, and intensity of exercise that is appropriate for each person, taking into account any complications or comorbidities. Local Integrated Care Boards (ICBs) commission these services in England, and availability may vary by area.

Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, which may be relevant for people exploring broader lifestyle and treatment options alongside exercise. People seeking support for insulin resistance should also speak to their GP, who can arrange relevant blood tests, assess cardiovascular risk, and refer to appropriate NHS services. NHS 111 can provide advice if you need guidance outside of GP hours.

Are there any risks or side effects of aerobic exercise if you have insulin resistance?

The main risk is hypoglycaemia in people taking insulin or sulphonylureas; blood glucose should be monitored before, during, and after exercise. Cardiovascular risk should be assessed before starting vigorous activity.

Aerobic exercise is generally safe for people with insulin resistance, but certain risks are worth understanding before starting or intensifying a programme. The most clinically relevant concern for people taking glucose-lowering medications, particularly insulin or sulphonylureas such as gliclazide, is hypoglycaemia (low blood sugar) during or after exercise. Aerobic activity increases glucose uptake by muscles, which can lower blood glucose levels significantly, especially during prolonged or vigorous sessions. Medications such as metformin and GLP-1 receptor agonists used on their own carry a much lower risk of causing hypoglycaemia.

If you take insulin or a sulphonylurea, monitor your blood glucose before, during, and after exercise, particularly when starting a new routine or increasing intensity. If your blood glucose is below 4 mmol/L, treat with 15 to 20 g of fast-acting carbohydrate, such as glucose tablets, a small glass of fruit juice, or a sugary drink. Recheck after 10 to 15 minutes and, once blood glucose has recovered, follow with a longer-acting carbohydrate snack if your next meal is not imminent. Do not drive if you have had a hypoglycaemic episode until your blood glucose has been stable and above 5 mmol/L for at least 45 minutes. Medication doses may need to be adjusted in discussion with a GP or diabetes specialist nurse; this should never be done without professional guidance.

Musculoskeletal injury is another consideration, particularly for people who are overweight or have been inactive for a long period. Starting with low-impact activities such as walking or swimming, warming up properly, and increasing intensity gradually all help to reduce this risk. People with existing complications of diabetes, such as peripheral neuropathy or pre-existing diabetic eye disease, should seek medical advice before beginning a new exercise programme, as certain activities may need to be modified. It is also advisable to avoid vigorous exercise when acutely unwell or dehydrated. If you take an SGLT2 inhibitor, speak to your GP or diabetes team before significantly increasing exercise intensity, as there is a rare risk of diabetic ketoacidosis with this medication class.

Cardiovascular risk should also be assessed in people with longstanding insulin resistance or type 2 diabetes before undertaking vigorous exercise. A GP can arrange an appropriate review. If you experience chest pain, severe breathlessness, or loss of consciousness during exercise, call 999 immediately. For other concerns that arise outside of GP hours, contact NHS 111 for advice. Suspected adverse effects from any medication can be reported via the MHRA Yellow Card scheme.

How to combine aerobic exercise with diet and medication for best results

Combining aerobic exercise with a diet low in refined carbohydrates produces greater reductions in HbA1c and visceral fat than either approach alone. Medications such as metformin or GLP-1 receptor agonists complement, but do not replace, lifestyle changes.

Combining aerobic exercise with dietary changes produces greater improvements in insulin sensitivity than either intervention alone, and this combination forms the foundation of evidence-based lifestyle management for insulin resistance. A diet that limits refined carbohydrates and ultra-processed foods, emphasises vegetables, wholegrains, legumes, and lean protein, and reduces overall caloric intake where weight loss is a goal, works synergistically with regular physical activity to reduce fasting glucose, HbA1c, and visceral fat.

Timing meals in relation to exercise may also be beneficial. Research suggests that exercising after a meal, particularly after the largest carbohydrate-containing meal of the day, can blunt the postprandial glucose rise more effectively than exercising in a fasted state for some individuals. However, individual responses vary, and people taking glucose-lowering medications that carry a hypoglycaemia risk should be cautious about exercising in a fasted state, as described in the previous section.

For people who require pharmacological treatment alongside lifestyle measures, a prescriber may consider medications such as metformin, GLP-1 receptor agonists, or dual GIP and GLP-1 receptor agonists. In the UK, semaglutide is available as two separate products with different licensed indications: Wegovy (semaglutide) is authorised by the MHRA for chronic weight management, while Ozempic (semaglutide) is authorised for type 2 diabetes.^[22][23] Tirzepatide (Mounjaro) is authorised in the UK by the MHRA both for type 2 diabetes and for chronic weight management.^[25][26] NICE Technology Appraisals set out the criteria for NHS use of these medicines, and local ICBs make commissioning decisions. These treatments are intended to complement, not replace, lifestyle changes including exercise. Following an online consultation with Bolt Pharmacy, a prescriber may consider weight-management treatments where clinically appropriate.

Regular review with a GP, diabetes nurse, or dietitian helps ensure that exercise, diet, and any medication are working together effectively. Blood glucose monitoring, HbA1c testing, and weight tracking provide objective data to guide adjustments. Building a sustainable routine, rather than pursuing rapid short-term changes, is the approach most likely to produce lasting improvements in insulin sensitivity.

Scientific References

1. Canonical and Alternative Pathways (Insulin and Exercise) of GLUT4 Synthesis, Signaling, Intracellular Clustering, and Recruitment to the Plasma Membrane.
2. General aspects of muscle glucose uptake.
3. Role of oxidative stress in impaired insulin signaling associated with exercise-induced muscle damage.
4. Combination of imeglimin and resistance exercise improves mitochondrial function and glucose metabolism in skeletal muscles.
5. MOTS-c interacts synergistically with exercise intervention to regulate PGC-1α expression, attenuate insulin resistance and enhance glucose metabolism in mice via AMPK signaling pathway.
6. Effect of acute high-intensity intermittent swimming on post-exercise insulin responsiveness in epitrochlearis muscle of fed rats.
7. Effects of Acute Exercise Combined With Calorie Restriction Initiated Late-in-Life on Insulin Signaling, Lipids, and Glucose Uptake in Skeletal Muscle From Old Rats.
8. Physical activity guidelines: UK Chief Medical Officers' report.
9. UK Chief Medical Officers' physical activity guidelines (full report).
10. Physical activity guidelines for adults aged 19 to 64.
11. Comparative effectiveness of high-intensity interval training vs moderate-intensity continuous training.
12. Comparative effects of long- and short-interval aerobic high-intensity interval training on glycemic control among individuals with type 2 diabetes: a network meta-analysis.
13. Characteristics of High-Intensity Interval Training Influence Anthropometrics, Glycemic Control, and Cardiorespiratory Fitness in Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
14. The Acute Effects of Interrupting Prolonged Sitting Time in Adults with Standing and Light-Intensity Walking on Biomarkers of Cardiometabolic Health in Adults: A Systematic Review and Meta-analysis.
15. Metabolic Effects of Breaking Prolonged Sitting With Standing or Light Walking in Older South Asians and White Europeans: A Randomized Acute Study.
16. Type 2 diabetes in adults: management (NG28).
17. Type 2 diabetes: prevention in people at high risk (PH38).
18. Diabetes mellitus: assessing fitness to drive.
19. SGLT2 inhibitors: updated advice on the risk of diabetic ketoacidosis.
20. EMA confirms recommendations to minimise ketoacidosis risk with SGLT2 inhibitors in diabetes.
21. Empagliflozin 10 mg film-coated tablets – SGLT2 inhibitors: advice on the risk of diabetic ketoacidosis (safety alert).
22. Semaglutide – BNF drug monograph.
23. First GLP-1 tablet for weight loss approved in the UK (Wegovy semaglutide tablet).
24. Semaglutide (Wegovy, Ozempic, Rybelsus).
25. MHRA authorises diabetes drug Mounjaro (tirzepatide) for weight management and weight loss.
26. Tirzepatide – BNF drug monograph.

Frequently Asked Questions